Gene · 10850
Papers2,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Involvement of increased arginase-1+ group 2 innate lymphoid cells and myeloid-derived suppressor cells in endometrial carcinoma: A pilot study. | J Int Med Res | 2026 | 41912235 | PubTator, text mining | PubMed |
| Post-Acute Sequelae Patients with Severe COVID-19 History Show a Prolonged Inflammatory, Vascular Injury Pattern. | Eur J Immunol | 2026 | 41906594 | PubTator, text mining | PubMed |
| Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuries. | J Immunother Cancer | 2026 | 41895713 | PubTator, text mining | PubMed |
| TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size. | Nat Immunol | 2026 | 41862649 | PubTator, text mining | PubMed |
| Diagnostic concordance of dermatopathology and PCR in differentiating eczema from psoriasis. | J Eur Acad Dermatol Venereol | 2026 | 41814865 | PubTator, text mining | PubMed |
| Risk Factors and Biomarkers for Immune Checkpoint Inhibitor-mediated Hepatotoxicity: Emerging Insights and Future Perspectives. | J Clin Transl Hepatol | 2026 | 41810106 | PubTator, text mining | PubMed |
| The Dual Role of Extracellular Vesicles in Aging and Age-Related Diseases: Pathophysiology and Therapeutic Potential. | Int J Nanomedicine | 2026 | 41810000 | PubTator, text mining | PubMed |
| Beyond inflammation: alarmins as critical drivers of pulmonary fibrosis. | ERJ Open Res | 2026 | 41809871 | PubTator, text mining | PubMed |
| Computational discovery of precision therapeutics for hidradenitis suppurativa. | bioRxiv | 2026 | 41799800 | PubTator, text mining | PubMed |
| Mucosal Remodeling in Chronic Rhinosinusitis with Nasal Polyps: The Role of Innate Lymphoid Cells and Reprogramming Under IL-4Rα Blockade. | Int J Mol Sci | 2026 | 41752128 | PubTator, text mining | PubMed |
| Circulating Clues in Ménière's Disease: Elevated Cell-Free DNA and a Pro-Inflammatory Signature in Patients' Blood. | Int J Mol Sci | 2026 | 41752086 | PubTator, text mining | PubMed |
| The Mystery of the Hidden Trace: Emerging Genetic Approaches to Improve Body Fluid Identification. | Genes (Basel) | 2026 | 41751530 | PubTator, text mining | PubMed |
| The Role of Rarely Studied Chemokines in Tumor Progression in Multiple Myeloma (MM). | Cancers (Basel) | 2026 | 41749925 | PubTator, text mining | PubMed |
| Host Serum Biomarker Signatures in Mycobacteriologically Cured Pulmonary Tuberculosis Patients with Persistent Lung Inflammation on 18F-FDG PET/CT. | Diseases | 2026 | 41745108 | PubTator, text mining | PubMed |
| The Neuro-Bone Axis in Metastatic Progression: Innervation, Neuro-Immune-Osteoclast Crosstalk, and Therapeutic Opportunities. | Biology (Basel) | 2026 | 41744673 | PubTator, text mining | PubMed |
| Exploring the Causal Relationship Between Inflammatory Cytokines and Joint Pain: A Mendelian Randomization Study. | Pain Res Manag | 2026 | 41737894 | PubTator, text mining | PubMed |
| Innovative approaches targeting innate immune cells to promote organ transplant tolerance. | Front Transplant | 2026 | 41737588 | PubTator, text mining | PubMed |
| CCL27 regulates immune responses and angiogenesis in skin wound healing process. | J Invest Dermatol | 2026 | 41722765 | PubTator, text mining | PubMed |
| Targeted inhibition of PI3K/Akt by luteolin-rich Hydrilla verticillata in TNF-α and IFN-γ-induced atopic keratinocytes. | Fitoterapia | 2026 | 41720354 | PubTator, text mining | PubMed |
| Inflammatory Mediators of Alzheimer's Disease Characterized in a Mouse Model (APP/PS1). | NeuroSci | 2026 | 41718152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10850/papers?page=2